HSD17B3 (P37058) variants and mutations
HSD17B3 (also known as P37058) is a human protein-coding gene encoding a 17-beta-hydroxysteroid dehydrogenase type 3 protein. It converts androstenedione to testosterone in the testes, providing a key step in androgen synthesis during male sexual development. Biallelic loss-of-function variants cause 17-beta-hydroxysteroid dehydrogenase 3 deficiency, a 46,XY disorder of sex development. This analysis covers 501 HSD17B3 variants and mutations. Of these, 97% have computational variant effect predictions. Disease context includes 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3, pseudohermaphroditism, and hereditary disease. Example HSD17B3 variants include M1I, M1V, and D3Y.
Variant analysis overview
- Gene: HSD17B3
- Protein: P37058
- UniProt accession: P37058
- Organism: Homo sapiens
- Variants analyzed: 501
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 352 unspecified-consequence records; 1 stop retained variant; 65 missense variants; 58 synonymous variants; 7 stop-gained variants; 4 splice-region variants; 4 in-frame deletions; 11 frameshift variants; 1 in-frame insertions
- Prediction scores: 488 variants have prediction scores (97% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: 46,XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3, pseudohermaphroditism, hereditary disease, disorder of sexual differentiation, Genetic 46,XY disorder of sex development, arthropathy, Meniere disease, Hypocalcemia, knee fracture, posterior cortical atrophy, endometriosis, Berardinelli-Seip congenital lipodystrophy.
Protein structure and variant hotspots
- Protein features: 2 binding sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable HSD17B3 variants
Examples include M1I, M1V, D3Y, V4I, E6K, L11F, L11I, L11R. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1I (p.Met1Ile), rs2130805147, ClinGen CA374126781, ClinVar RCV002273837, MetaLR 0.44, MetaSVM -0.28, Likely pathogenic, Disorder of sexual differentiation
- M1V (p.Met1Val), rs1354232643, ClinGen CA374126784, ClinVar RCV003459907, MetaLR 0.39, MetaSVM -0.51, Likely pathogenic, Testosterone 17-beta-dehydrogenase deficiency
- D3Y (p.Asp3Tyr), TOPMed rs1278098965, gnomAD rs1278098965, REVEL 0.24, MetaLR 0.44
- V4I (p.Val4Ile), rs377018679, ClinGen CA5140562, cosmic curated COSV64557, ClinVar RCV004404479, REVEL 0.10, MetaLR 0.24, Uncertain significance, Inborn genetic diseases
- E6K (p.Glu6Lys), gnomAD rs1468885206, REVEL 0.29, MetaLR 0.45
- L11F (p.Leu11Phe), cosmic curated COSV64557, TOPMed rs1177857442, gnomAD rs1177857442, REVEL 0.13, MetaLR 0.23, Likely benign, Inborn genetic diseases
- L11I (p.Leu11Ile), NCI-TCGA Cosmic COSV6455, Variant assessed as somatic; moderate impact.
- L11R (p.Leu11Arg), Ensembl rs1827634702, REVEL 0.33, MetaLR 0.38
- T12I (p.Thr12Ile), TOPMed rs1461917416, MetaLR 0.24, MetaSVM -0.90
- L14M (p.Leu14Met), rs1407024099, ClinGen CA374126697, ClinVar RCV004404480, gnomAD rs1407024099, REVEL 0.28, MetaLR 0.46, Uncertain significance, Inborn genetic diseases
- V16A (p.Val16Ala), TOPMed rs1190128638, REVEL 0.36, MetaLR 0.40
- C17F (p.Cys17Phe), TOPMed rs868469733, gnomAD rs868469733, REVEL 0.37, MetaLR 0.43
- C17S (p.Cys17Ser), TOPMed rs868469733, gnomAD rs868469733
- C17Y (p.Cys17Tyr), TOPMed rs868469733, gnomAD rs868469733, REVEL 0.48, MetaLR 0.41
- L18Q (p.Leu18Gln), rs2490210603, ClinGen CA374126672, ClinVar RCV003566605, Uncertain significance, not provided
- A19T (p.Ala19Thr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L21P (p.Leu21Pro), rs1238780362, ClinGen CA374126653, ClinVar RCV001976927, TOPMed rs1238780362, REVEL 0.75, MetaLR 0.70, Uncertain significance, not provided
- L21V (p.Leu21Val), Ensembl rs781387334
- A22V (p.Ala22Val), ExAC rs775234559, TOPMed rs775234559, gnomAD rs775234559, REVEL 0.14, MetaLR 0.18, Uncertain significance, Testosterone 17-beta-dehydrogenase deficiency
- V25M (p.Val25Met), 1000Genomes rs114520006, ExAC rs114520006, TOPMed rs114520006, gnomAD rs114520006, REVEL 0.18, MetaLR 0.30
- C30G (p.Cys30Gly), rs770504476, ClinGen CA5140555, cosmic curated COSV64556, ClinVar RCV003280135, REVEL 0.18, MetaLR 0.36, Uncertain significance, Inborn genetic diseases
- C30R (p.Cys30Arg), ExAC rs770504476, TOPMed rs770504476, gnomAD rs770504476, Uncertain significance
- C30Y (p.Cys30Tyr), gnomAD rs1827633003, REVEL 0.16, MetaLR 0.20
- V31I (p.Val31Ile), rs2066480, ClinGen CA5140553, cosmic curated COSV64558, ClinVar RCV000364639, REVEL 0.20, MetaLR 0.02, Benign, not provided; Testosterone 17-beta-dehydrogenase deficiency
- V31L (p.Val31Leu), 1000Genomes rs2066480, ESP rs2066480, ExAC rs2066480, TOPMed rs2066480, REVEL 0.19, MetaLR 0.12, Benign
- L32S (p.Leu32Ser), ExAC rs770305727, TOPMed rs770305727, gnomAD rs770305727, REVEL 0.35, MetaLR 0.38
- N34H (p.Asn34His), TOPMed rs1338488980, gnomAD rs1338488980, REVEL 0.25, MetaLR 0.28
- Y35* (p.Tyr35Ter), rs2490210465, ClinGen CA374126560, ClinVar RCV003724535, Pathogenic
- W36* (p.Trp36Ter), NCI-TCGA Cosmic COSV6455, cosmic curated COSV64557, Variant assessed as somatic; high impact.
- K37E (p.Lys37Glu), 1000Genomes rs781518300, ExAC rs781518300, gnomAD rs781518300, REVEL 0.19, MetaLR 0.39, Uncertain significance, Inborn genetic diseases
- K37Q (p.Lys37Gln), 1000Genomes rs781518300, ExAC rs781518300, gnomAD rs781518300, REVEL 0.20, MetaLR 0.40
- V38G (p.Val38Gly), ExAC rs755152747, TOPMed rs755152747, gnomAD rs755152747, REVEL 0.32, MetaLR 0.43
- P40S (p.Pro40Ser), NCI-TCGA Cosmic COSV1009, cosmic curated COSV10093, MetaLR 0.75, MetaSVM 0.10, Variant assessed as somatic; moderate impact.
- K41Q (p.Lys41Gln), ExAC rs747173183, TOPMed rs747173183, gnomAD rs747173183, REVEL 0.23, MetaLR 0.40, Uncertain significance, Inborn genetic diseases
- F43L (p.Phe43Leu), TOPMed rs1827631401, MetaLR 0.61, MetaSVM 0.05
- L44S (p.Leu44Ser), cosmic curated COSV10750, Ensembl rs2130804958
- R45Q (p.Arg45Gln), cosmic curated COSV10093, 1000Genomes rs537079694, ExAC rs537079694, gnomAD rs537079694, REVEL 0.20, MetaLR 0.37
- R45W (p.Arg45Trp), rs139084702, ClinGen CA5140546, ClinVar RCV000879849, ClinVar RCV001167680, REVEL 0.39, MetaLR 0.62, Conflicting interpretations, not provided; HSD17B3-related disorder; Testosterone 17-beta-dehydrogenase defic
- S46P (p.Ser46Pro), gnomAD rs1344180452, REVEL 0.70, MetaLR 0.69
- M47L (p.Met47Leu), 1000Genomes rs191153391, ESP rs191153391, ExAC rs191153391, TOPMed rs191153391, REVEL 0.48, MetaLR 0.63, Pathogenic
- M47V (p.Met47Val), rs191153391, ClinGen CA5140543, ClinVar RCV003037330, ClinVar RCV004526221, REVEL 0.39, MetaLR 0.71, Pathogenic/Likely pathogenic, Testosterone 17-beta-dehydrogenase deficiency
- G48V (p.Gly48Val), TOPMed rs1276688568, MetaLR 0.91, MetaSVM 0.99
- Q49R (p.Gln49Arg), gnomAD rs1421360138, REVEL 0.46, MetaLR 0.53
- W50* (p.Trp50Ter), ExAC rs752426255, gnomAD rs752426255, CADD 37.00
- A51V (p.Ala51Val), ExAC rs767254534, TOPMed rs767254534, gnomAD rs767254534, REVEL 0.70, MetaLR 0.72
- V52A (p.Val52Ala), ExAC rs751278659, gnomAD rs751278659, REVEL 0.89, MetaLR 0.89, Uncertain significance, Inborn genetic diseases
- I53V (p.Ile53Val), ExAC rs550421995, gnomAD rs550421995, REVEL 0.44, MetaLR 0.32
- T54P (p.Thr54Pro), TOPMed rs1827448362, REVEL 0.93, MetaLR 0.98
- G55E (p.Gly55Glu), Ensembl rs111612997
- A56T (p.Ala56Thr), rs119481078, ClinGen CA117115, ClinVar RCV000005155, UniProt VAR 016067, REVEL 0.88, MetaLR 0.95, Likely pathogenic, Testosterone 17-beta-dehydrogenase deficiency
- A56V (p.Ala56Val), NCI-TCGA Cosmic COSV6455, cosmic curated COSV64557, REVEL 0.89, MetaLR 0.95, Variant assessed as somatic; moderate impact., in MPH
- D58G (p.Asp58Gly), rs765832166, ExAC rs765832166, TOPMed rs765832166, gnomAD rs765832166, REVEL 0.78, MetaLR 0.77, Variant assessed as somatic; moderate impact.
- D58N (p.Asp58Asn), NCI-TCGA Cosmic COSV1009, cosmic curated COSV10093, NCI-TCGA Cosmic COSV6455, gnomAD rs1827447788, REVEL 0.70, MetaLR 0.83, Variant assessed as somatic; moderate impact.
- D58V (p.Asp58Val), ExAC rs765832166, TOPMed rs765832166, gnomAD rs765832166, MetaLR 0.88, MetaSVM 0.89
- G59R (p.Gly59Arg), ExAC rs762242774, gnomAD rs762242774
- G61A (p.Gly61Ala), TOPMed rs1434456759, MetaLR 0.99, MetaSVM 0.96
- K62E (p.Lys62Glu), Ensembl rs2130800013
- A63V (p.Ala63Val), TOPMed rs1220119827, gnomAD rs1220119827, REVEL 0.83, MetaLR 0.91, Uncertain significance, not specified
- Y64C (p.Tyr64Cys), rs2130799996, ClinGen CA374126366, cosmic curated COSV64556, ClinVar RCV003557457, REVEL 0.65, MetaLR 0.76, Uncertain significance, not provided
- S65A (p.Ser65Ala), 1000Genomes rs562239313, ExAC rs562239313, gnomAD rs562239313, REVEL 0.25, MetaLR 0.07
- S65L (p.Ser65Leu), rs747329682, ClinGen CA351299, NCI-TCGA Cosmic COSV6455, cosmic curated COSV64556, REVEL 0.56, MetaLR 0.58, Pathogenic/Likely pathogenic, not provided; Testosterone 17-beta-dehydrogenase deficiency
- S65W (p.Ser65Trp), ExAC rs747329682, TOPMed rs747329682, gnomAD rs747329682, REVEL 0.55, MetaLR 0.78, Likely pathogenic, in MPH
- E67* (p.Glu67Ter), rs1017003712, ClinGen CA374126349, ClinVar RCV003821744, AlphaMissense 0.60, MetaLR 0.66, Pathogenic
- E67K (p.Glu67Lys), rs1017003712, ClinGen CA10627745, NCI-TCGA Cosmic COSV6455, cosmic curated COSV64558, REVEL 0.69, AlphaMissense 0.60, Uncertain significance, Testosterone 17-beta-dehydrogenase deficiency
- L68R (p.Leu68Arg), rs2490091018, ClinGen CA374126323, ClinVar RCV003459909, ClinVar RCV004701065, Conflicting interpretations, not specified; Testosterone 17-beta-dehydrogenase deficiency
- A69G (p.Ala69Gly), Ensembl rs1825570777, MetaLR 0.84, MetaSVM 0.85
- K70Q (p.Lys70Gln), Ensembl rs955299087, MetaLR 0.73, MetaSVM 0.11
- R71C (p.Arg71Cys), ESP rs375673180, ExAC rs375673180, TOPMed rs375673180, gnomAD rs375673180, REVEL 0.42, MetaLR 0.80
- R71H (p.Arg71His), rs1029381659, cosmic curated COSV10890, TOPMed rs1029381659, REVEL 0.20, MetaLR 0.50, Variant assessed as somatic; moderate impact.
- R71S (p.Arg71Ser), ESP rs375673180, ExAC rs375673180, TOPMed rs375673180, gnomAD rs375673180, REVEL 0.50, MetaLR 0.70
- L73F (p.Leu73Phe), rs370158010, ESP rs370158010, ExAC rs370158010, TOPMed rs370158010, REVEL 0.24, MetaLR 0.59, Variant assessed as somatic; moderate impact.
- N74D (p.Asn74Asp), TOPMed rs1825569984, gnomAD rs1825569984, REVEL 0.28, MetaLR 0.48
- N74K (p.Asn74Lys), Ensembl rs1554695412, MetaLR 0.48, MetaSVM -0.32
- N74S (p.Asn74Ser), ExAC rs780178733, TOPMed rs780178733, gnomAD rs780178733, REVEL 0.36, MetaLR 0.62, Uncertain significance, not specified
- N74T (p.Asn74Thr), rs780178733, ClinGen CA5140489, ClinVar RCV001796081, ClinVar RCV003558414, REVEL 0.57, MetaLR 0.73, Pathogenic/Likely pathogenic, Testosterone 17-beta-dehydrogenase deficiency; not provided
- V75G (p.Val75Gly), NCI-TCGA TCGA novel, MetaLR 0.96, MetaSVM 1.09, Variant assessed as somatic; moderate impact.
- V76F (p.Val76Phe), TOPMed rs1825569712
- L77V (p.Leu77Val), TOPMed rs1478715937, REVEL 0.58, MetaLR 0.79
- I78S (p.Ile78Ser), Ensembl rs891443639, MetaLR 0.73, MetaSVM 0.54
- R80Q (p.Arg80Gln), rs119481075, ClinGen CA117112, ClinVar RCV000005150, ClinVar RCV000255553, REVEL 0.85, MetaLR 0.90, Pathogenic, Differences in sex development; not provided; Testosterone 17-beta-dehydrogenase
- R80W (p.Arg80Trp), rs119481077, ClinGen CA117114, cosmic curated COSV64558, ClinVar RCV000005153, REVEL 0.80, MetaLR 0.91, Pathogenic/Likely pathogenic, not provided; Testosterone 17-beta-dehydrogenase deficiency
- T81M (p.Thr81Met), cosmic curated COSV64556, ExAC rs746859258, TOPMed rs746859258, gnomAD rs746859258, REVEL 0.64, MetaLR 0.87, Conflicting interpretations, not provided; Differences in sex development; not specified
- T81P (p.Thr81Pro), rs2130733506, ClinGen CA374126250, ClinVar RCV001993644, Ensembl rs2130733506, REVEL 0.69, MetaLR 0.79, Uncertain significance, not provided
- L82R (p.Leu82Arg), TOPMed rs1408993881, gnomAD rs1408993881, REVEL 0.48, MetaLR 0.46
- L82V (p.Leu82Val), gnomAD rs1447402833, REVEL 0.09, MetaLR 0.40
- E83G (p.Glu83Gly), TOPMed rs1332228281, gnomAD rs1332228281, REVEL 0.44, MetaLR 0.76
- E83K (p.Glu83Lys), cosmic curated COSV64557, Ensembl rs867098476
- K84N (p.Lys84Asn), TOPMed rs1002359024, MetaLR 0.85, MetaSVM 0.87
- L85P (p.Leu85Pro), NCI-TCGA Cosmic COSV6455, cosmic curated COSV64556, Variant assessed as somatic; moderate impact.
- A87S (p.Ala87Ser), TOPMed rs1158193512, gnomAD rs1158193512, REVEL 0.07, MetaLR 0.46
- A87T (p.Ala87Thr), TOPMed rs1158193512, gnomAD rs1158193512, REVEL 0.12, MetaLR 0.50
- A87V (p.Ala87Val), gnomAD rs1418328762, REVEL 0.27, MetaLR 0.58
- I88F (p.Ile88Phe), ExAC rs750133798, gnomAD rs750133798, REVEL 0.32, MetaLR 0.64
- I88T (p.Ile88Thr), gnomAD rs1444508567, REVEL 0.30, MetaLR 0.43
- I88V (p.Ile88Val), ExAC rs750133798, gnomAD rs750133798, REVEL 0.24, MetaLR 0.24
- A89V (p.Ala89Val), NCI-TCGA Cosmic COSV6455, cosmic curated COSV64557, MetaLR 0.81, MetaSVM 0.30, Variant assessed as somatic; moderate impact.
- T90A (p.Thr90Ala), ExAC rs778582108, gnomAD rs778582108, REVEL 0.21, MetaLR 0.42
- I92=, rs143401138, NCI-TCGA Cosmic COSV6455, Variant assessed as somatic; low impact.
- E93* (p.Glu93Ter), cosmic curated COSV10093, ExAC rs753360928, TOPMed rs753360928, gnomAD rs753360928, CADD 50.00, SIFT 0.00, Pathogenic
- E93K (p.Glu93Lys), rs753360928, ClinGen CA5140482, cosmic curated COSV64557, ClinVar RCV003324315, REVEL 0.58, MetaLR 0.60, Pathogenic, not provided; Testosterone 17-beta-dehydrogenase deficiency
- R94G (p.Arg94Gly), ExAC rs753222380, gnomAD rs753222380, REVEL 0.25, MetaLR 0.46
- R94L (p.Arg94Leu), 1000Genomes rs539588932, ExAC rs539588932, gnomAD rs539588932, REVEL 0.16, MetaLR 0.60
- R94Q (p.Arg94Gln), rs539588932, NCI-TCGA Cosmic COSV6455, cosmic curated COSV64557, 1000Genomes rs539588932, REVEL 0.12, MetaLR 0.44, Variant assessed as somatic; moderate impact.
- R94W (p.Arg94Trp), ExAC rs753222380, gnomAD rs753222380, REVEL 0.29, MetaLR 0.72
- T96A (p.Thr96Ala), cosmic curated COSV64558, TOPMed rs1368601617, gnomAD rs1368601617, REVEL 0.33, MetaLR 0.35
- G97A (p.Gly97Ala), ExAC rs755385508, TOPMed rs755385508, gnomAD rs755385508, REVEL 0.48, MetaLR 0.83
- G97R (p.Gly97Arg), Ensembl rs1564030988, REVEL 0.52, MetaLR 0.81
- R98S (p.Arg98Ser), NCI-TCGA TCGA novel, SIFT 0.00, Variant assessed as somatic; moderate impact.
- S99N (p.Ser99Asn), 1000Genomes rs569337274, ExAC rs569337274, TOPMed rs569337274, gnomAD rs569337274, REVEL 0.09, MetaLR 0.52
- S99R (p.Ser99Arg), NCI-TCGA Cosmic COSV6455, cosmic curated COSV64558, ExAC rs766577166, gnomAD rs766577166, REVEL 0.22, MetaLR 0.40, Uncertain significance, Inborn genetic diseases
- I102F (p.Ile102Phe), rs116436956, ClinGen CA5140456, ClinVar RCV000898707, ClinVar RCV003922924, REVEL 0.47, MetaLR 0.39, Likely benign, not provided
- I102M (p.Ile102Met), Ensembl rs1587729627, MetaLR 0.29, MetaSVM -0.84
- I103T (p.Ile103Thr), ExAC rs760740918, TOPMed rs760740918, gnomAD rs760740918, REVEL 0.76, MetaLR 0.88
- A105G (p.Ala105Gly), ExAC rs775606025, gnomAD rs775606025, REVEL 0.57, MetaLR 0.75
- A105T (p.Ala105Thr), rs761942775, ClinGen CA5140454, ClinVar RCV003245226, ExAC rs761942775, REVEL 0.40, MetaLR 0.64, Uncertain significance, Inborn genetic diseases
- D106G (p.Asp106Gly), TOPMed rs1825478350, MetaLR 0.98, MetaSVM 1.00
- T108I (p.Thr108Ile), gnomAD rs897533007, REVEL 0.71, MetaLR 0.88, Uncertain significance, Inborn genetic diseases
- T108R (p.Thr108Arg), NCI-TCGA Cosmic COSV1009, cosmic curated COSV10093, MetaLR 0.84, MetaSVM 0.83, Variant assessed as somatic; moderate impact.
- D110G (p.Asp110Gly), rs200961609, ClinGen CA5140450, ClinVar RCV002937770, ESP rs200961609, REVEL 0.37, MetaLR 0.42, Uncertain significance, not provided
- D110N (p.Asp110Asn), NCI-TCGA TCGA novel, ESP rs150424854, ExAC rs150424854, TOPMed rs150424854, REVEL 0.25, MetaLR 0.48, Uncertain significance
- D110Y (p.Asp110Tyr), rs150424854, ClinGen CA5140451, ClinVar RCV001167678, ClinVar RCV005348335, REVEL 0.52, MetaLR 0.62, Uncertain significance, Inborn genetic diseases; Testosterone 17-beta-dehydrogenase deficiency
- D111E (p.Asp111Glu), 1000Genomes rs35189151, ESP rs35189151, ExAC rs35189151, TOPMed rs35189151, REVEL 0.21, MetaLR 0.51, Benign
- I112V (p.Ile112Val), rs2130730164, ClinGen CA374125592, ClinVar RCV002008795, Ensembl rs2130730164, REVEL 0.52, MetaLR 0.62, Uncertain significance, not provided
- E114K (p.Glu114Lys), rs568096279, NCI-TCGA Cosmic COSV6455, cosmic curated COSV64556, 1000Genomes rs568096279, REVEL 0.25, MetaLR 0.37, Variant assessed as somatic; moderate impact.
- H115P (p.His115Pro), TOPMed rs1365962179, gnomAD rs1365962179, REVEL 0.26, MetaLR 0.37, Uncertain significance, Inborn genetic diseases
- H115R (p.His115Arg), TOPMed rs1365962179, gnomAD rs1365962179, REVEL 0.21, MetaLR 0.24
- I116N (p.Ile116Asn), ExAC rs777366638, gnomAD rs777366638, REVEL 0.77, MetaLR 0.83
- K117E (p.Lys117Glu), TOPMed rs1474582477, gnomAD rs1474582477, REVEL 0.39, MetaLR 0.29
- E118* (p.Glu118Ter), rs2490085916, ClinGen CA374125494, ClinVar RCV003671044, CADD 36.00, Pathogenic
- E118G (p.Glu118Gly), TOPMed rs1825474809, REVEL 0.54, MetaLR 0.78
- A121S (p.Ala121Ser), Ensembl rs1587729516, REVEL 0.23, MetaLR 0.54
- A121T (p.Ala121Thr), rs1587729516, ClinGen CA374125463, ClinVar RCV003443339, REVEL 0.24, MetaLR 0.64, Uncertain significance, not provided
- G122V (p.Gly122Val), TOPMed rs1825474448, REVEL 0.64, MetaLR 0.79
- I125T (p.Ile125Thr), TOPMed rs1158599463, REVEL 0.81, MetaLR 0.86
- G126R (p.Gly126Arg), rs1409554313, ClinGen CA374125429, ClinVar RCV003314294, TOPMed rs1409554313, REVEL 0.80, MetaLR 0.87, Uncertain significance, Testosterone 17-beta-dehydrogenase deficiency
- I127T (p.Ile127Thr), NCI-TCGA TCGA novel, MetaLR 0.66, MetaSVM 0.45, Variant assessed as somatic; moderate impact.
- L128* (p.Leu128Ter), rs767765046, ClinGen CA196624271, ClinVar RCV003724460, ExAC rs767765046, CADD 27.60, Pathogenic
- L128S (p.Leu128Ser), rs767765046, ClinGen CA5140445, ClinVar RCV000581861, ClinVar RCV005431780, REVEL 0.93, MetaLR 0.97, Uncertain significance, not specified
- V129F (p.Val129Phe), Ensembl rs2130730101
- N130S (p.Asn130Ser), rs119481079, ClinGen CA117116, ClinVar RCV000005156, ClinVar RCV001818138, REVEL 0.87, MetaLR 0.87, Pathogenic/Likely pathogenic, not provided; Testosterone 17-beta-dehydrogenase deficiency
- N131H (p.Asn131His), ExAC rs772902740, TOPMed rs772902740, gnomAD rs772902740, REVEL 0.90, MetaLR 0.95
- N131I (p.Asn131Ile), ESP rs139029268, ExAC rs139029268, TOPMed rs139029268, gnomAD rs139029268, MetaLR 0.95, MetaSVM 1.07
- N131S (p.Asn131Ser), ESP rs139029268, ExAC rs139029268, TOPMed rs139029268, gnomAD rs139029268, REVEL 0.88, MetaLR 0.93
- N131Y (p.Asn131Tyr), ExAC rs772902740, TOPMed rs772902740, gnomAD rs772902740, REVEL 0.90, MetaLR 0.96
- V132A (p.Val132Ala), TOPMed rs1825407679, REVEL 0.69, MetaLR 0.52
- V132D (p.Val132Asp), TOPMed rs1825407679, MetaLR 0.92, MetaSVM 1.04
- G133R (p.Gly133Arg), rs747724352, ClinGen CA5140428, cosmic curated COSV64556, ClinVar RCV000583122, REVEL 0.90, MetaLR 0.97, Pathogenic, Pseudohermaphroditism
- M134R (p.Met134Arg), gnomAD rs1825407309, REVEL 0.90, MetaLR 0.72
- P136A (p.Pro136Ala), Ensembl rs2130727738
- P136S (p.Pro136Ser), NCI-TCGA Cosmic COSV6455, cosmic curated COSV64557, MetaLR 0.42, MetaSVM -0.57, Variant assessed as somatic; moderate impact.
- N137D (p.Asn137Asp), gnomAD rs1238875020, REVEL 0.11, MetaLR 0.30
- N137K (p.Asn137Lys), TOPMed rs1825406959, REVEL 0.21, MetaLR 0.38
- N137S (p.Asn137Ser), TOPMed rs1181298867, gnomAD rs1181298867, REVEL 0.17, MetaLR 0.23
- L139F (p.Leu139Phe), ExAC rs780685404, gnomAD rs780685404, REVEL 0.20, MetaLR 0.23
- P140A (p.Pro140Ala), TOPMed rs1825406571
- P140L (p.Pro140Leu), ESP rs146271877, ExAC rs146271877, TOPMed rs146271877, gnomAD rs146271877
- P140Q (p.Pro140Gln), ESP rs146271877, ExAC rs146271877, TOPMed rs146271877, gnomAD rs146271877, REVEL 0.68, MetaLR 0.76
- P140S (p.Pro140Ser), NCI-TCGA TCGA novel, MetaLR 0.74, MetaSVM 0.48, Variant assessed as somatic; moderate impact.
- S141N (p.Ser141Asn), TOPMed rs1211043907, gnomAD rs1211043907, REVEL 0.24, MetaLR 0.53, Uncertain significance, Inborn genetic diseases
- H142R (p.His142Arg), gnomAD rs1353496108, REVEL 0.41, MetaLR 0.29
- H142Y (p.His142Tyr), NCI-TCGA Cosmic COSV6455, cosmic curated COSV64557, Variant assessed as somatic; moderate impact.
- N145K (p.Asn145Lys), 1000Genomes rs115684579, ESP rs115684579, ExAC rs115684579, TOPMed rs115684579, REVEL 0.34, MetaLR 0.58, Likely benign
- N145S (p.Asn145Ser), TOPMed rs1825405825, MetaLR 0.54, MetaSVM -0.54
- A146E (p.Ala146Glu), gnomAD rs1227310598, REVEL 0.24, MetaLR 0.62
- A146S (p.Ala146Ser), 1000Genomes rs779332674, ExAC rs779332674, gnomAD rs779332674, REVEL 0.30, MetaLR 0.38
- A146T (p.Ala146Thr), rs779332674, NCI-TCGA Cosmic COSV1009, cosmic curated COSV10093, 1000Genomes rs779332674, REVEL 0.27, MetaLR 0.34, Likely benign, Inborn genetic diseases
- A146V (p.Ala146Val), gnomAD rs1227310598, REVEL 0.26, MetaLR 0.43
- P147L (p.Pro147Leu), rs371906721, ClinGen CA5140420, ClinVar RCV002779217, ESP rs371906721, REVEL 0.38, MetaLR 0.59, Uncertain significance, Inborn genetic diseases
- P147S (p.Pro147Ser), TOPMed rs1002934063, gnomAD rs1002934063, REVEL 0.26, MetaLR 0.30
- P147T (p.Pro147Thr), TOPMed rs1002934063, gnomAD rs1002934063
- D148Y (p.Asp148Tyr), NCI-TCGA TCGA novel, REVEL 0.44, MetaLR 0.89, Variant assessed as somatic; moderate impact.
- E149D (p.Glu149Asp), TOPMed rs1253596999, REVEL 0.33, MetaLR 0.27
- E149K (p.Glu149Lys), NCI-TCGA Cosmic COSV6455, cosmic curated COSV64556, Variant assessed as somatic; moderate impact.
- S152G (p.Ser152Gly), gnomAD rs1359243413, REVEL 0.11, MetaLR 0.39
- S152I (p.Ser152Ile), gnomAD rs1275902342, REVEL 0.53, MetaLR 0.54
- S152N (p.Ser152Asn), gnomAD rs1275902342, REVEL 0.20, MetaLR 0.22
- S152R (p.Ser152Arg), cosmic curated COSV64557, Ensembl rs1587724901, REVEL 0.33, MetaLR 0.25
- L153F (p.Leu153Phe), ExAC rs772442387, gnomAD rs772442387, REVEL 0.57, MetaLR 0.68
- H155Y (p.His155Tyr), NCI-TCGA Cosmic COSV6455, cosmic curated COSV64557, REVEL 0.64, MetaLR 0.82, Variant assessed as somatic; moderate impact.
- N157D (p.Asn157Asp), ExAC rs779419888, gnomAD rs779419888, REVEL 0.91, MetaLR 0.95
Public HSD17B3 analysis runs
- HSD17B3 analysis run — HSD17B3 (501 variants) — completed 2026-08-22